Business Context and Reporting Period
Company: Lifecore Biomedical, Inc. (LFCR)
Filing Type: Form 8-K (Current Report)
Date of Report: January 31, 2023
Subject: Non-reliance on previously issued financial statements due to identified errors.
Key Financial Metrics
This filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The report focuses on the identification of errors in prior financial statements rather than current period performance metrics.
Material Changes and Restatement Details
- Non-Reliance Determination: The Audit Committee concluded that the consolidated financial statements for the year ended May 29, 2022, and the unaudited statements for the three months ended August 28, 2022, should no longer be relied upon.
- Cause of Error: Errors were identified related to certain non-cash impairment charges associated with the Company's Curation Foods business.
- Materiality Assessment: The errors are deemed material under SEC Staff Accounting Bulletin No. 99 and No. 108, necessitating a restatement.
- Scope of Impact: The restatement is not expected to impact the Lifecore segment or Other segment financial information, nor is it expected to adversely affect operations, liquidity, or the overall business plan.
- Internal Controls: The Company expects to conclude there was a material weakness in internal control over financial reporting specifically relating to impairment analysis.
Outlook, Management Commentary, and Risks
- Next Steps: The Company intends to file amended Form 10-K/A and Form 10-Q/A reports containing the restated financial statements as soon as practicable.
- Auditor Engagement: The Audit Committee has discussed these matters with the independent registered public accounting firm, Ernst & Young LLP (EY).
- Risks and Uncertainties: Forward-looking statements regarding the restatement are subject to risks, including the possibility that additional information may emerge, the timing of EY's audit conclusions, and potential delays in filing the amended reports.
Investor Verification Checklist
- Verify the specific quantitative impact of the non-cash impairment charge errors on net income and equity once the amended reports are filed.
- Monitor the filing of the amended Form 10-K/A and Form 10-Q/A for the restated financial data.
- Review the detailed disclosure regarding the material weakness in internal controls over financial reporting in the upcoming filings.
- Confirm whether the errors affect any other segments beyond the Curation Foods business as the restatement process concludes.